Related references
Note: Only part of the references are listed.Magnolol alleviates Alzheimer's disease-like pathology in transgenic C. elegans by promoting microglia phagocytosis and the degradation of beta-amyloid through activation of PPAR-gamma
Zhishen Xie et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Piperine attenuates cognitive impairment in an experimental mouse model of sporadic Alzheimer's disease
Che Wang et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2019)
Isorhynchophylline exerts antidepressant-like effects in mice via modulating neuroinflammation and neurotrophins: involvement of the PI3K/Akt/GSK-3β signaling pathway
Yan-Fang Xian et al.
FASEB JOURNAL (2019)
Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease
Hui-Qin Li et al.
BRAIN BEHAVIOR AND IMMUNITY (2019)
NF-κB activation in astrocytes drives a stage-specific beneficial neuroimmunological response in ALS
Najwa Ouali Alami et al.
EMBO JOURNAL (2018)
Magnolol abrogates chronic mild stress-induced depressive-like behaviors by inhibiting neuroinflammation and oxidative stress in the prefrontal cortex of mice
Jie Cheng et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
The Montreal Cognitive Assessment: Normative Data from a German-Speaking Cohort and Comparison with International Normative Samples
Alessandra E. Thomann et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Motor coordination and synaptic plasticity deficits are associated with increased cerebellar activity of NADPH oxidase, CAMKII, and PKC at preplaque stage in the TgCRND8 mouse model of Alzheimer's disease
Roberto Russo et al.
NEUROBIOLOGY OF AGING (2018)
Safety and Toxicology of Magnolol and Honokiol
Andrea Sarrica et al.
PLANTA MEDICA (2018)
Isorhynchophylline alleviates learning and memory impairments induced by aluminum chloride in mice
Hui-Qin Li et al.
CHINESE MEDICINE (2018)
Effects of a Dehydroevodiamine-Derivative on Synaptic Destabilization and Memory Impairment in the 5xFAD, Alzheimer's Disease Mouse Model
Shinwoo Kang et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2018)
Effect of magnolol on cerebral injury and blood brain barrier dysfunction induced by ischemia-reperfusion in vivo and in vitro
Xiaoyan Liu et al.
METABOLIC BRAIN DISEASE (2017)
Beneficial effect of magnolol on lupus nephritis in MRL/lpr mice by attenuating the NLRP3 inflammasome and NF-κB signaling pathway: A mechanistic analysis
Feng Huang et al.
MOLECULAR MEDICINE REPORTS (2017)
Fluoxetine administration during adolescence attenuates cognitive and synaptic deficits in adult 3 x TgAD mice
Dong-Sheng Sun et al.
NEUROPHARMACOLOGY (2017)
Indirubin Derivative 7-Bromoindirubin-3-Oxime (7Bio) Attenuates Aβ Oligomer-Induced Cognitive Impairments in Mice
Liping Chen et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
GSK-3β deletion in dentate gyrus excitatory neuron impairs synaptic plasticity and memory
Enjie Liu et al.
SCIENTIFIC REPORTS (2017)
Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases
Yu Tang et al.
MOLECULAR NEUROBIOLOGY (2016)
Curcumin Attenuates Beta-Amyloid-Induced Neuroinflammation via Activation of Peroxisome Proliferator-Activated Receptor-Gamma Function in a Rat Model of Alzheimer's Disease
Zun-Jing Liu et al.
FRONTIERS IN PHARMACOLOGY (2016)
Neuroinflammation in Alzheimer's disease
Michael T. Heneka et al.
LANCET NEUROLOGY (2015)
Immune attack: the role of inflammation in Alzheimer disease
Frank L. Heppner et al.
NATURE REVIEWS NEUROSCIENCE (2015)
NF-kappaB Signaling Pathways in Neurological Inflammation: A Mini Review
Ruey-Horng Shih et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2015)
Isorhynchophylline Treatment Improves the Amyloid-beta-Induced Cognitive Impairment in Rats via Inhibition of Neuronal Apoptosis and Tau Protein Hyperphosphorylation
Yan-Fang Xian et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Neuroinflammation in the pathogenesis of Alzheimer's disease. A rational framework for the search of novel therapeutic approaches
Inelia Morales et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Revisiting the framework of the National Institute on Aging-Alzheimer's Association diagnostic criteria
Maria C. Carrillo et al.
ALZHEIMERS & DEMENTIA (2013)
Activator or inhibitor? GSK-3 as a new drug target
Fumi Takahashi-Yanaga
BIOCHEMICAL PHARMACOLOGY (2013)
Effects of Magnolol on Impairment of Learning and Memory Abilities Induced by Scopolamine in Mice
Yang-si Li et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2013)
Long-term supplementation of honokiol and magnolol ameliorates body fat accumulation, insulin resistance, and adipose inflammation in high-fat fed mice
Young-Je Kim et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2013)
NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice
Michael T. Heneka et al.
NATURE (2013)
Oxidative Stress and the Pathogenesis of Alzheimer's Disease
Yan Zhao et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)
Immune surveillance in the central nervous system
Shalina S. Ousman et al.
NATURE NEUROSCIENCE (2012)
Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model
Siva Sundara Kumar Durairajan et al.
NEUROBIOLOGY OF AGING (2012)
The Genetics of Alzheimer Disease
Rudolph E. Tanzi
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Aβ-Degrading Enzymes: Potential for Treatment of Alzheimer Disease
James Scott Miners et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
The nuclear signaling of NF-kappa B: current knowledge, new insights, and future perspectives
Fengyi Wan et al.
CELL RESEARCH (2010)
Microglia and Inflammation in Alzheimer's Disease
Shweta Mandrekar-Colucci et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2010)
γ-secretases: from cell biology to therapeutic strategies
Bruno A. Bergmans et al.
LANCET NEUROLOGY (2010)
Honokiol and Magnolol as Multifunctional Antioxidative Molecules for Dermatologic Disorders
Jui-Lung Shen et al.
MOLECULES (2010)
Neuroprotective Effect of Honokiol and Magnolol, Compounds from Magnolia officinalis, on Beta-amyloid-induced Toxicity in PC12 Cells
Chu Peng Hoi et al.
PHYTOTHERAPY RESEARCH (2010)
Synaptic degeneration in Alzheimer's disease
Thomas Arendt
ACTA NEUROPATHOLOGICA (2009)
Magnolol and honokiol prevent learning and memory impairment and cholinergic deficit in SAMP8 mice
Nobuaki Matsui et al.
BRAIN RESEARCH (2009)
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
Ganesh M. Shankar et al.
NATURE MEDICINE (2008)
Increased expression of Aβ degrading enzyme IDE in the cortex of transgenic mice with Alzheimer's disease-like neuropathology
Saila Vepsalainen et al.
NEUROSCIENCE LETTERS (2008)
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Michelle L. Block et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Neuroprotective activity of honokiol and magnolol in cerebellar granule cell damage
Yi-Ruu Lin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
NF-κB pathway:: a target for preventing β-amyloid (Aβ)-induced neuronal damage and Aβ42 production
A Valerio et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Cholinesterase inhibitors for Alzheimer's disease
J Birks
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2006)
Glycogen synthase kinase 3 beta and Alzheimer's disease: pathophysiological and therapeutic significance
Y. Balaraman et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Amyloid-beta precursor protein processing in neurodegeneration
V Wilquet et al.
CURRENT OPINION IN NEUROBIOLOGY (2004)
Histone H3 phosphorylation by IKK-α is critical for cytokine-induced gene expression
Y Yamamoto et al.
NATURE (2003)
GSK-3α regulates production of Alzheimer's disease amyloid-β peptides
CJ Phiel et al.
NATURE (2003)
Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695
MA Chishti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
BACE1 is the major β-secretase for generation of Aβ peptides by neurons
HB Cai et al.
NATURE NEUROSCIENCE (2001)
Share Paper
